Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CNS Pharmaceuticals, Inc. | 1,517 | reported | 17 Nov 2025 | tx 12+333,184 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Nov 2025 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 1,517 | 0.00 USD | deriv |
| 08 Apr 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 17,500 | — | deriv |
| 08 Apr 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 17,500 | — | deriv |
| 01 Feb 2024 | PURCHASE | CNS Pharmaceuticals, Inc. | 33,333 | 0.30 USD | |
| 01 Feb 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 33,333 | — | deriv |
| 01 Feb 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 33,333 | — | deriv |
| 21 Sept 2023 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 68,961 | — | deriv |
| 19 Apr 2023 | PURCHASE | CNS Pharmaceuticals, Inc. | 2,500 | 1.70 USD | |
| 10 Apr 2023 | PURCHASE | CNS Pharmaceuticals, Inc. | 7,173 | 0.74 USD | |
| 15 Jul 2021 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 32,000 | — | deriv |
| 12 Jun 2020 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 46,559 | — | deriv |